PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | CRVS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.07 | -2.0% | 3.43 | 3.48 | 3.35 | 3.47 | 3.50 | 17:59:47 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.00 | 3.80 | 0.80 | 21.05% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 276 | 19,195 | $ 3.43 | $ 65,842 | 106,063 | 2.53 - 8.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:43 | 222 | $ 3.43 | USD |
Corvus Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 100.81M | 29.39M | $ -46.94M | -1.75 | - | 29.13M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 15.00 | 0.90% |
Corvus Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/17/2019 | 08:30 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Provide Business Update and Report.. |
| 10/03/2019 | 08:30 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Present Updated Data from CPI-006.. |
| 8/08/2019 | 17:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 8/08/2019 | 17:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 8/08/2019 | 16:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 8/07/2019 | 16:58 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 8/07/2019 | 16:05 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Present at the 2019 Wedbush.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRVS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.29 | 3.70 | 3.09 | 3.52 | 92,317 | 0.14 | 4.26% |
| 1 Month | 3.40 | 3.70 | 2.53 | 3.00 | 101,179 | 0.03 | 0.88% |
| 3 Months | 3.97 | 4.48 | 2.53 | 3.52 | 122,278 | -0.54 | -13.6% |
| 6 Months | 4.23 | 8.10 | 2.53 | 4.45 | 139,032 | -0.80 | -18.91% |
| 1 Year | 7.85 | 8.46 | 2.53 | 4.58 | 120,009 | -4.42 | -56.31% |
| 3 Years | 14.62 | 22.1366 | 2.53 | 8.56 | 102,116 | -11.19 | -76.54% |
| 5 Years | 15.00 | 22.1366 | 2.53 | 9.08 | 93,973 | -11.57 | -77.13% |
Corvus Pharmaceuticals Description
| Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer. |
